Ramsay, Mary

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

Lopez Bernal, J., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Stowe, J., Tessier, E., Groves, N., Dabrera, G., et al. (2021) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 2,889

Effectiveness of COVID-19 vaccines against the B.1.617.2 variant

Bernal, J. L., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Stowe, J., Tessier, E., Groves, N., Dabrera, G., et al. (2021) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 2,888

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

Lopez Bernal, J., Andrews, N., Gower, C., Robertson, C., Stowe, J., Tessier, E., Simmons, R., Cottrell, S., Roberts, R., O’Doherty, M., et al. (2021) · BMJ

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 1,389

Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England

Bernal, J. L., Andrews, N., Gower, C., Stowe, J., Robertson, C., Tessier, E., Simmons, R., Cottrell, S., Roberts, R., O’Doherty, M., et al. (2021) · BMJ

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 1,389

SARS-CoV-2 evolution during treatment of chronic infection

Kemp, S. A., Collier, D. A., Datir, R. P., Ferreira, I. A. T. M., Gayed, S., Jahun, A., Hosmillo, M., Rees-Spear, C., Mlcochova, P., Lumb, I. U., et al. (2021) · Nature

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 1,097

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

Volz, E., Hill, V., McCrone, J. T., Price, A., Jorgensen, D., O’Toole, Á., Southgate, J., Johnson, R., Jackson, B., Nascimento, F. F., et al. (2021) · Cell

SARS-CoV-2 and COVID-19 ResearchEvolution and Genetic Dynamics

Cited by 1,006

Effectiveness of maternal pertussis vaccination in England: an observational study

Amirthalingam, G., Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Donegan, K., Fry, N. K., Miller, E., & Ramsay, M. (2014) · The Lancet

Bacterial Infections and VaccinesVaccine Coverage and Hesitancy

Cited by 739

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Collier, D. A., De Marco, A., Ferreira, I. A. T. M., Meng, B., Datir, R. P., Walls, A. C., Kemp, S. A., Bassi, J., Pinto, D., Silacci-Fregni, C., et al. (2021) · Nature

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 728

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

Trotter, C. L., Andrews, N. J., Kaczmarski, E. B., Miller, E., & Ramsay, M. E. (2004) · The Lancet

Bacterial Infections and VaccinesMicrobial infections and disease research

Cited by 571

Factors underlying parental decisions about combination childhood vaccinations including MMR: A systematic review

Brown, K. F., Kroll, J. S., Hudson, M. J., Ramsay, M., Green, J., Long, S. J., Vincent, C. A., Fraser, G., & Sevdalis, N. (2010) · Vaccine

Vaccine Coverage and HesitancyEthics and Legal Issues in Pediatric Healthcare

Cited by 412

Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection

Zuo, J., Dowell, A. C., Pearce, H., Verma, K., Long, H. M., Begum, J., Aiano, F., Amin-Chowdhury, Z., Hoschler, K., Brooks, T., et al. (2021) · Nature Immunology

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 392

A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013

Dabrera, G., Amirthalingam, G., Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Fry, N. K., & Ramsay, M. (2015) · Clinical Infectious Diseases

Bacterial Infections and VaccinesDiphtheria, Corynebacterium, and Tetanus

Cited by 385

Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

Graham, M. S., Sudre, C. H., May, A., Antonelli, M., Murray, B., Varsavsky, T., Kläser, K., Canas, L. S., Molteni, E., Modat, M., et al. (2021) · The Lancet Public Health

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 304

Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction

Amirthalingam, G., Campbell, H., Ribeiro, S., Fry, N. K., Ramsay, M., Miller, E., & Andrews, N. (2016) · Clinical Infectious Diseases

Bacterial Infections and VaccinesDiphtheria, Corynebacterium, and Tetanus

Cited by 275

Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study

Parikh, S. R., Andrews, N. J., Beebeejaun, K., Campbell, H., Ribeiro, S., Ward, C., White, J. M., Borrow, R., Ramsay, M. E., & Ladhani, S. N. (2016) · The Lancet

Bacterial Infections and VaccinesNeonatal and Maternal Infections

Cited by 275

Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England

Cohen, C., White, J. M., Savage, E. J., Glynn, J. R., Choi, Y., Andrews, N., Brown, D., & Ramsay, M. E. (2007) · Emerging infectious diseases

Virology and Viral DiseasesBacterial Infections and Vaccines

Cited by 241

COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England

Kirsebom, F. C. M., Andrews, N., Stowe, J., Toffa, S., Sachdeva, R., Gallagher, E., Groves, N., O'Connell, A.-M., Chand, M., Ramsay, M., et al. (2022) · The Lancet Infectious Diseases

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 182

Estimating Haemophilus influenzae Type b Vaccine Effectiveness in England and Wales by Use of the Screening Method

Ramsay, M. E., McVernon, J., Andrews, N. J., Heath, P. T., & Slack, M. P. (2003) · The Journal of Infectious Diseases

Bacterial Infections and VaccinesPneumonia and Respiratory Infections

Cited by 172

Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study

Stowe, J., Andrews, N., Kirsebom, F., Ramsay, M., & Bernal, J. L. (2022) · Nature Communications

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 166

Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004–11: an observational study

Okike, I. O., Ribeiro, S., Ramsay, M. E., Heath, P. T., Sharland, M., & Ladhani, S. N. (2014) · The Lancet Infectious Diseases

Bacterial Infections and VaccinesInfectious Diseases and Tuberculosis

Cited by 138

The effectiveness of the mumps component of the MMR vaccine: a case control study

Harling, R., White, J. M., Ramsay, M. E., Macsween, K. F., & Bosch, C. V. D. (2005) · Vaccine

Virology and Viral DiseasesVaccine Coverage and Hesitancy

Cited by 132

Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines

Ladhani, S. N., Flood, J. S., Ramsay, M. E., Campbell, H., Gray, S. J., Kaczmarski, E. B., Mallard, R. H., Guiver, M., Newbold, L. S., & Borrow, R. (2012) · Vaccine

Bacterial Infections and VaccinesMicrobial infections and disease research

Cited by 124

Seven-fold increase in viral meningo-encephalitis reports in England and Wales during 2004–2013

Kadambari, S., Okike, I., Ribeiro, S., Ramsay, M. E., Heath, P. T., Sharland, M., & Ladhani, S. N. (2014) · Journal of Infection

Infectious Encephalopathies and EncephalitisViral Infections and Immunology Research

Cited by 58

Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in England

Møller Kirsebom, F. C., Andrews, N., Stowe, J., Groves, N., Chand, M., Ramsay, M., & Bernal, J. L. (2022) · The Lancet Regional Health - Europe

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 31